What additional notification is required to inform a patient of a generic substitution?

Informing a patient of a generic substitution is typically required to be done orally. This requirement ensures that the patient receives immediate and direct communication about the change in their medication. The rationale behind this requirement focuses on the importance of the patient understanding the implications of the substitution, including any potential differences in efficacy, side effects, or experiences with the generic compared to the brand-name drug.

While other forms of communication such as text messages, emails, or notifications through healthcare providers may be beneficial for documentation or follow-up, they do not fulfill the legal obligation for immediate patient notification regarding a change in their prescribed medication. Oral communication allows for a two-way conversation where the patient can ask questions and express concerns, which is crucial for ensuring patient safety and understanding.